first glp 1 approved Evolution of GLP‐1 Receptor Agonists for Diabetes Treatment Generic Liraglutide Approved, Marking First

doi:10.4161/cc.8.24.10242

Side effects are minimal, typically limited to mild injection site redness

Novo did not provide additional data comparing oral versus injectable Wegovy in its Friday release

Nurses should check that patients understand the chronic nature of treatment

Lawrance R, Degtyarev E, Griffiths P et al (2020) What is an estimand & how does it relate to quantifying the effect of treatment on patient-reported quality of life outcomes in clinical trials

For weight management, medications such as semaglutide (Wegovy) are licensed for adults with a BMI of 30 kg/m or above, or 27 kg/m with weight-related comorbidities